■原著論文

1. Funatsu T, Yamashita A, Kaku S, Iwatsuki Y, Asada Y. Plasma factor Xa inhibition can predict antithrombotic effects of oral direct factor Xa inhibitors in rabbit atherothrombosis models. Thromb Haemost. 2012; 108: 896-902.

2. Yamashita A, Nishihira K, Matsuura Y, Ito T, Kawahara K, Hatakeyama K, Hashiguchi T, Maruyama I, Yagi H, Matsumoto M, Fujimura Y, Kitamura K, Shibata Y, Asada Y. Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus. Atherosclerosis. 2012; 224: 511-4.

3. Matsuura Y, Hatakeyama K, Imamura T, Tsuruda T, Shibata Y, Kodama T, Kitamura K, Asada Y. Different distribution of Pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques. J Atheroscler Thromb . 2012; 19: 837-45.

4. Iwakiri T, Yano Y, Sato Y, Hatakeyama K, Marutsuka K, Fujimoto S, Kitamura K, Kario K, Asada Y. Usefulness of carotid intima-media thickness measurement as an indicator of generalized atherosclerosis: Findings from autopsy analysis. Atherosclerosis. 2012; 225: 359-62.

5. Kuroki M, Nakada H, Yamashita A, Sawaguchi A, Uchino N, Sato S, Asanuma T, Asada Y, Tamura S. Loss of cellular viability in areas of ground-glass opacity on computed tomography images immediately after pulmonary radiofrequency ablation in rabbits. Jpn J Radiol. 2012; 30: 323-30.

6. Nishihira K, Hatakeyama K, Kuriyama N, Nomura K, Fukushima Y, Inoue Y, Nakama T, Mine D, Sagara S, Ashikaga K, Matsuyama A, Kitamura K, Shibata Y, Asada Y. Presence of older thrombus in patients with late and very late drug-eluting stent thrombosis. J Cardiol. 2012; 59: 57-63.

7. Sato Y, Ishibashi-Ueda H, Iwakiri T, Ikeda Y, Matsuyama T, Hatakeyama K, Asada Y. Thrombus components in cardioembolic and atherothrombotic strokes. Thromb Res. 2012; 130: 278-80.

8. Hatakeyama K, Kaneko MK, Kato Y, Ishikawa T, Nishihira K, Tsujimoto Y, Shibata Y, Ozaki Y, Asada Y. Podoplanin expression in advanced atherosclerotic lesions of human aortas. Thromb Res. 2012; 129: e70-6.

9. Tsuruda T, Hatakeyama K, Nagamachi S, Sekita Y, Sakamoto S, Endo GJ, Nishimura M, Matsuyama M, Yoshimura K, Sato Y, Onitsuka T, Imamura T, Asada Y, Kitamura K. Inhibition of development of abdominal aortic aneurysm by glycolysis restriction. Arterioscler Thromb Vasc Biol. 2012; 32: 1410-7.

10. Satomi-Kobayashi S, Kinugasa M, Kobayashi R, Hatakeyama K, Kurogane Y, Ishida T, Emoto N, Asada Y, Takai Y, Hirata K, Rikitake Y. Osteoblast-like differentiation of cultured human coronary artery smooth muscle cells by bone morphogenetic protein endothelial cell precursor-derived regulator (BMPER). J Biol Chem. 2012; 287: 30336-45.

11. Nakahata S, Saito Y, Marutsuka K, Hidaka T, Maeda K, Hatakeyama K, Shiraga T, Goto A, Takamatsu N, Asada Y, Utsunomiya A, Okayama A, Kubuki Y, Shimoda K, Ukai Y, Kurosawa G, Morishita K. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma. Leukemia. 2012; 26: 1238-46.

12. Nagano M, Hatakeyama K, Kai M, Nakamura H, Yodoi J, Asada Y, Chijiiwa K. Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma. HPB (Oxford). 2012; 14: 573-82.

13. Umekita K, Kaneko Y, Yorita K, Hashiba Y, Matsuda M, Miyauchi S, Ueno S, Takajo I, Kusumoto N, Nagatomo Y, Marutsuka K, Okayama A. Arthropathy with infiltrate IgG4-positive plasma cells in synovium. Rheumatology (Oxford). 2012; 51: 580-2.

14. Shide K, Kameda T, Shimoda H, Yamaji T, Abe H, Kamiunten A, Sekine M, Hidaka T, Katayose K, Kubuki Y, Yamamoto S, Miike T, Iwakiri H, Hasuike S, Nagata K, Marutsuka K, Iwama A, Matsuda T, Kitanaka A, Shimoda K. TET2 is essential for survival and hematopoietic stem cell homeostasis. Leukemia. 2012; 26: 2216-23.

15. Miyake K, Aratake Y, Sakaguchi T, Kiyoyama K, Kuribayashi T, Marutsuka K, Ohno E. Examination of CD26/DPPIV, p53, and PTEN expression in thyroid follicular adenoma. Diagnostic Cytopathology. 2012; 40: 1047-53.

16. Kanai T, Kuwabara M, Tanaka-Totoribe N, Nakamura E, Matsuo Y, Gamoh S, Suzuki A, Asada Y, Hisa H, Yamamoto R. Insulin Induces Internalization of the Plasma Membrane 5-Hydroxytryptamine(2A) (5-HT(2A)) Receptor in the Isolated Human Endothelium-Denuded Saphenous Vein via the Phosphatidylinositol 3-Kinase Pathway. J Pharmacol Sci. 2012; 118:178-85.

■著書

1. Yamashita A, Asada Y. Pathology and pathophysiology of atherothrombosis: Virchow’s triad revisited. In: Traditional and novel risk factors in atherothrombosis. Gaxiola (ed). Intech, 1-20. (2012)

■総説

1. 盛口淸香、浅田祐士郎：血小板と動脈硬化、Pharma Medica　2012; 30: 21-6.

2. 山下　篤、浅田祐士郎：第XI因子阻害薬、内科　2012; 101 : 79-82.

3. 畠山金太、鶴田敏博、島尾義也、中田　博、浅田祐士郎：大動脈周囲炎、後腹膜線維症、心血管系の慢性炎症、別冊BIO Clinica　慢性炎症と疾患　2012; 1: 52-8.

4. 畠山金太、浅田祐士郎：感染・炎症と動脈硬化―人体病理からみた動脈硬化と血栓症についてー、血栓止血誌　2012; 23: 265-73.

5. 畠山金太、浅田祐士郎：動脈硬化の炎症―ヒトの病理からみた動脈硬化の進展機構についてー、血管医学　2012; 23: 265-73.

6. 畠山金太：糖尿病に合併する冠動脈病変の特徴、べんちのーと　2012; 23: 7.

7. 浅田祐士郎：血管病理からみた血栓形成メカニズム、血栓止血誌　2012; 23: 606-10.

8. 浅田祐士郎：血栓症の形成メカニズムはどこまで解明されたか？　内科2012; 110: 5-10.

9. 浅田祐士郎：心血管イベントの発生における血栓形成機序の病理形態、顕微鏡2012; 47: 87-91.

10. 浅田祐士郎：出血性副作用のない抗血栓薬、medicina 2012; 49: 1046-8.

11. 浅田祐士郎：閉塞性動脈硬化の原因・病的意義、日本医事新報2012; 4583: 60-1.

12. 浅田祐士郎：血栓性疾患の発症における血小板と凝固系の関与、Modern Physician 2012; 32: 708-11.

13. 浅田祐士郎：動脈硬化の発生・進展と血栓形成－病理像からみたアテローム血栓症の発生機序－、加齢皮膚医学セミナー 2012; 7: 1-7.

■症例報告

1. Yoshioka I, Marutsuka K, Igawa K, Nagata J, Yoshida M, Baba T, Ichiki T, Kondoh Y, Takamori K, Kashima K, Sakoda S.: Epidermal choristoma arising on the midline gingiva as a congenital epulis: A case report. Journal of Cranio-Maxillofacial Surgery. 2012; 40:812-4.

2. Mizukami T, Obara M, Nishikomori R, Kawai T, Tahara Y, Sameshima N, Marutsuka K, Nakase H, Kimura N, Heike T, Nunoi H. Successful treatment with Infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. Journal of Clinical Immunology. 2012; 32: 39-49.

3. Yamashita S, Ryu S, Miyata S, Uchinokura S, Yokogami K, Uehara H, Moriguchi S, Iwakiri T, Marustuka K, Ikenoue M, Sawa D, Yamada N, Kodama Y, Takeshima H. A huge intraventricular congenital anaplastic astrocytoma: case report with Histopathological and genetic consideration. Brain Tumor Pathology. 2012; 29: 107-12.

4. Kawano N, Ono N, Yoshida S, Kuriyama T, Yamashita K, Beppu K, Shimao Y, Marutsuka K, Ueda Y, Ueda A.: Successful Treatment of Immunodeficiency-Associated EBV-Negative Lymphoproliferative Disorders in Rheumatoid Arthritis by Methotrexate Withdrawal and Prevention of its Relapse by Rituximab Administration. J Clin Exp Hematop. 2012; 52: 193-8.

5. 坂田恵理子、佐藤勇一郎、畠山金太、丸塚浩助、肥後貴史、西内伸輔、高橋典子、浅田祐士郎：卵巣純粋型絨毛癌の１例、診断病理　2012; 29: 294-7.

6. 塩屋悠斗、佐藤勇一郎、山下 篤、丸塚浩助、山内憲之、福島和子、上森照代、鮫島 浩、浅田祐士郎：卵巣粘液嚢胞腺腫より発生した大細胞神経内分泌癌の1例、診断病理　2012; 29: 146-9.

7. 盛口淸香、丸塚浩助、浅田祐士郎、前久保理恵、持田耕介、瀬戸山充：良性類上皮様末梢神経鞘腫瘍の1例、診断病理　2012; 29: 264-7.

8. 佐藤勇一郎、鮫島直樹、畠山金太、丸塚浩助、上森照代、福島和子、山内憲之、鮫島浩、浅田祐士郎：”浸潤性微小乳頭状腺癌構造”を伴う子宮体癌の一例、日本婦人科病理学会誌　2012; 3: 81-3.

9. 鮫島直樹、丸塚浩助、下村貴宏、賀本敏行、浅田祐士郎：High grade prostatic intraepithelial neoplasia, small cell neuroendocrine variant を伴った前立腺癌の一例、診断病理　2012; 29: 39-43.

10. 綾部貴典、富田雅樹、盛口淸香、丸塚浩助、清水哲哉：術前診断が困難であった対側肺転移を伴う肺類基底細胞癌の１切除例、日本呼吸器外科学会雑誌　2012; 26: 439-43.

11. 新甫武也、内之倉俊朗、横上聖貴、上原久生、丸塚浩助、福島 剛、塩見一剛、京楽 格、小玉隆男、矢野貴徳、竹島秀雄：原発性脳腫瘍との鑑別に苦慮したtumefactive multiple sclerosisの1例、脳神経外科ジャーナル　2012; 21: 625-30.